Sign In

Also in this Section

The Cholestatic and Biliary Diseases Special Interest Group (SIG) is an international community of investigators and practitioner focusing on preventing diagnosing and treating cholestatic liver diseases, as well as diseases of the biliary tree (choangiopathies). The SIG also strongly focuses on understanding the pathophysiology and on the genetics of cholestatic and biliary diseases as a way to identify novel therapeutic targets. The SIG promotes national and international collaborations and networks and registries to speed up the rate of discoveries and to facilitate clinical trials in an area that includes several rare diseases.

Consortium of Autoimmune Liver Diseases

Learn about opportunities to participate in the new Consortium of Autoimmune Liver Diseases [PDF]. Goals include increasing participation of North American investigators and centers; providing a platform for researchers to initiate investigations into knowledge gaps unique to North America; and recruiting investigators, both new and established, into the field of cholestatic and biliary disorders.

SIG Leadership

  • Mario Strazzabosco, MD, PhD, FAASLD
  • Christopher L Bowlus, MD, FAASLD
  • David N Assis, MD
  • Meena Ananthanarayanan, PhD, FAASLD
    Steering Committee
  • Olivier Barbier, PhD
    Steering Committee
  • Luca Fabris, MD, PhD
    Steering Committee
  • Marlyn J Mayo, MD, FAASLD
    Steering Committee
  • Carlo Spirli, PhD
    Steering Committee
  • Bette Anne Preston
    Staff Liaison